drugset / Trial / NCT04364022

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland

NCT04364022

Phase 3 Completed 326 enrolled Calmy Alexandra
RandomizedParallel-groupOpen-labelPrevention

Summary

A study to assess, in a two-arm open-label cluster randomized clinical trial, the efficacy of a 5-day course of LPV/r treatment in preventing COVID-19 in asymptomatic individuals exposed to a SARS-CoV-2 documented index patient, compared to surveillance alone.

Timeline

Start
2020-04-23
Primary completion
2021-03-24
Completion
2021-03-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lopinavir Other / unclassified 200 mg Oral
Comparator Ritonavir Other / unclassified 50 mg Oral

Indications

No indication recorded.